SCHEMBL29088901

SCHEMBL29088901

CN(Cc1cc(F)ccc1OCCC(=O)O)c1ccn2ncc([N+](=O)[O-])c2n1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 8/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ NTRK3 Q16288 3/20 0.36
▸ NTRK2 Q16620 3/20 0.36
▸ RXRA P19793 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ S1PR4 O95977 1/20 0.35
▸ JAK2 O60674 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CCNT1 O60563 2/20 0.34
▸ CDK9 P50750 2/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ SNCA P37840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29088983 0.96 NPC1 (0.40) NTRK1NPC1MAPK1HTTSMN1; SMN2
SCHEMBL29088904 0.89 NTRK1 (0.37) NTRK1KDM4ENTRK3NTRK2S1PR4
SCHEMBL29088974 0.87 NTRK1 (0.40) NTRK1NPC1MAPK1HTTSMN1; SMN2
SCHEMBL29088980 0.84 NTRK1 (0.42) NTRK1NTRK3NTRK2ALDH1A1CCNT1
SCHEMBL29088907 0.82 SMPD3 (0.44) NTRK1NTRK3NTRK2JAK2
SCHEMBL16936085 0.78 NTRK1 (0.45) NTRK1NTRK3NTRK2JAK2
SCHEMBL29088906 0.75 SMPD3 (0.42) NTRK1NTRK3NTRK2JAK2
SCHEMBL21229250 0.73 NTRK1 (0.43) NTRK1NTRK3NTRK2JAK2
SCHEMBL21229251 0.72 NTRK1 (0.45) NTRK1NTRK3NTRK2JAK2
SCHEMBL22660234 0.70 KDM4E (0.48) NPC1KDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110156813-B Heterocyclic compounds as TRK inhibitors 北京诺诚健华医药科技有限公司 2023-07-25 — — CN disclosed
Send feedback